EP0439182B1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Improved method of amplifying target nucleic acids applicable to both polymerase and ligase chain reactions
Assignee: Abbott Laboratories
•
Filing: 1991-01-25
•
Granted: 1996-04-24
•
Expires: 2011-01-25
Abstract
Abstract The present invention involves methods of improving LCR and PCR amplification schemes by modifying at least one probe/primer end so that the probability of the probe/primer contributing to spurious signal development is greatly reduced. Only after specific hybridization of the modified probe/primer with true target, are the modified ends "corrected" in a target dependent fashion to allow participation of the probe/primer in the enzymatic assembly reaction. Specific modifications depend on whether the assembly is done by ligation (as in LCR) or by extension/elongation (as in PCR). <IMAGE>
Inventors
- 👤 Keith C. Backman
- 👤 John J. Carrino
- 👤 Sheila B. Bond
- 👤 Thomas G. Laffler
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-30 00:23
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C07; C07H; C07H21/00; C12Q1/6844; C12Q1/6853; C12Q1/6858; C12Q1/686; C12Q1/6862; C12Q1/6876; C12Q1/6883; C12Q2600/00; C12Q2600/156; Y; Y10; Y10S; Y10S435/00; Y10S435/81
Claims Analysis
Total Claims: 22
Claim 1
Independent Claim
180 words
A method of amplifying a target nucleic acid sequence enzymatically to yield amplification products, wherein an enzyme utilizes: a nucleic acid initiator; the target sequence or amplification product to which it hybridizes as a template; and at least one additional nucleoside-containing reactant which can be enzymatically assembled to form amplification products complementary to the target, the amplification products themselves serving as further templates; said method characterized in that it comprises: (a) providing requisite initiators capable of hybridizing with the target, wherein at least one of the initiators is modified such that, when the initiator is hybridized, the enzyme is substantially incapable of acting on the initiator as its substrate, so that amplification product is not assembled; (b) hybridizing the initiator to the target, if present, to form an initiator-template complex; (c) correcting the modification in a target dependent manner to allow the initiator-template complex to be acted upon by the enzyme; (d) enzymatically assembling an amplification product; and (e) dissociating the amplification product from the target and repeating the hybridization, correction and assembling steps to amplify the desired target sequence.
Claim 2
Dependent Claim
38 words
The method of Claim 1 wherein said modification of at least one initiator (step a) comprises a blocking moiety attached to said initiator such that it blocks a chemical group required in the enzymatic assembly of step d.
Claim 3
Dependent Claim
35 words
The method of Claim 2 wherein the blocking moiety is of the form: wherein Z is selected from the group consisting of -H;-(CH₂) n CHO, where n is from 1 to 3; -deoxyribose; and -dideoxyribose.
Claim 4
Dependent Claim
33 words
The method of Claim 2 wherein said blocking moiety is a nucleic acid overhang, provided that if the enzymatic assembly of step d occurs by extension, the overhang includes a non-extendable 3' terminus.
Claim 5
Dependent Claim
53 words
The method of Claim 4 wherein said overhang is selected from among: a. ribonucleotides when said initiator comprises deoxyribonucleotides; b. an oligonucleotide having at least one abasic residue; and c. an oligonucleotide having a residue selected so that, upon hybridization of the modified initiator, with a target strand, a base pair mismatch results.
Claim 6
Dependent Claim
58 words
The method of Claim 2 or 4 wherein said correction of the modification comprises the use of an agent selected from: a. RNAse H enzyme; b. an endonuclease that cleaves a nucleic acid strand at an abasic site substantially only when the strand is hybridized to a complementary strand; c. endonuclease IV; and d. a mismatch repair enzyme.
Claim 7
Dependent Claim
50 words
The method of Claim 6 wherein the blocking moiety is of the form: wherein Z is selected from the group consisting of -H; -(CH₂) n CHO, where n is from 1 to 3; -deoxyribose; and -dideoxyribose; and wherein said correction of the modification comprises the use of an endonuclease IV.
Claim 8
Dependent Claim
37 words
The method of claim 1 wherein the enzyme is a polymerase, the initiator comprises a primer, the nucleoside-containing reactant comprises individual nucleoside triphosphates, and the amplification product comprises an extension product made from primer and nucleoside triphosphates.
Claim 9
Dependent Claim
37 words
The method of claim 1 wherein the enzyme is a ligase, the initiator is a first oligonucleotide probe, the nucleoside-containing reactant is a second oligonucleotide probe, and the amplification product comprises fused first and second oligonucleotide probes.
Claim 10
Dependent Claim
313 words
The method of claim 8 wherein the modified initiator(s) of step (a) includes a first probe hybridizable to a first segment of the target, a second probe hybridizable to a second segment of the target, a third probe hybridizable to the first probe and a fourth probe hybridizable to the second probe, wherein, as the modification; (i) the 5' end of the first segment of the target is spaced from the 3' end of the second segment by X n bases, each X being independently selected from a set N consisting of from one to any three of the four bases, and n being any integer greater than or equal to 1; (ii) the third probe hybridizes to the first probe, such that the base on the first probe complementary to the 5' end of the third probe is spaced from the 3' end of the first probe by Y m bases, each Y being independently selected from a set M consisting of from zero to any three of the four bases, and m being zero or any integer greater than or equal to 1, provided that at least one base remains unused in the X n and Y m sequences to comprise the set not N and not M, and that the sequence of X n bases is not complementary to the sequence of Y m bases; and (iii) the base adjacent the 5' end of X n and the base adjacent the 5' end of Y m are selected from a set Q, which consists of not N and not M; and wherein said step (c) comprises extending the first probe to fill the X n gap, and optionally the fourth probe to fill the Y m gap, using an excess of deoxy X' triphosphates and deoxy Y' triphosphates, wherein X' and Y' represent the complements of X and Y, respectively.
Claim 11
Dependent Claim
12 words
The method of Claim 10 wherein n equals from 1 to 5.
Claim 12
Dependent Claim
9 words
The method of Claim 10 wherein m equals zero.
Claim 13
Dependent Claim
21 words
The method of claim 10 wherein n equals from 1 to 5; and m independently also equals from 1 to 5.
Claim 14
Dependent Claim
31 words
The method of claim 10 wherein the deoxy X' triphosphates added during step c comprise bases modified to contain a marker selected from the group consisting of labels, hooks and haptens.
Claim 15
Dependent Claim
36 words
The method according to Claim 10, and comprising the further step of detecting the presence of amplified target sequences by means of a hapten marker attached to the 5' ends of the second and third probes.
Claim 16
Dependent Claim
126 words
A diagnostic kit comprising in combination: (a) an initiator selected from either two pairs of probes hybridizable with target such that they are capable of being ligated in LCR or a pair of primers hybridizable with target so as to be capable of initiating PCR, wherein at least one of the probes or primers is modified such that, when the initiator is hybridized, a ligase or polymerase is substantially incapable of acting on the initiator as its substrate; (b) an assembling reagent selected from either a ligase or a polymerase enzyme for assembling an amplification product; and (c) a correcting reagent capable of correcting the modified probe/primer in a target dependent manner to allow the probe/primer-template complex to be acted upon by the ligase or polymerase.
Claim 17
Dependent Claim
36 words
The kit of Claim 16 wherein the blocking moiety is of the form: wherein Z is selected from the group consisting of -H; -(CH₂) n CHO, where n is from 1 to 3; -deoxyribose; and -dideoxyribose.
Claim 18
Dependent Claim
51 words
The kit of Claim 16 wherein the correcting reagent comprises an agent selected from: a. RNAse H enzyme; b. an endonuclease that cleaves a nucleic acid strand at an abasic site substantially only when the strand is hybridized to a complementary strand; c. endonuclease IV; and d. a mismatch repair enzyme.
Claim 19
Dependent Claim
26 words
The kit of Claim 16 wherein the initiator comprises two pairs of probes, the assembling reagent comprises a ligase, and the correcting reagent comprises a polymerase.
Claim 20
Dependent Claim
23 words
The kit of claim 16 wherein at least one probe contains a marker selected from the group consisting of labels, hooks and haptens.
Claim 21
Independent Claim
455 words
A method for distinguishing a first, target nucleic acid sequence from a second, nontarget sequence which differs from the target by the identity of at least one base, said method comprising: a. providing an excess of each of four probes, a first probe complementary to a first segment of the target, a second probe complementary to a second segment of the target, a third probe complementary to the first probe and a fourth probe complementary to the second probe, (i) wherein the 5' end of the first segment of the target is spaced from the 3' end of the second segment by X n bases, each X being independently selected from a set N consisting of from one to any three of the four bases, and n being any integer greater than or equal to 1; (ii) wherein the third probe hybridizes to the first probe, such that the base on the first probe complementary to the 5' end of the third probe is spaced from the 3' end of the first probe by Y m bases, each Y being independently selected from a set M consisting of from zero to any three of the four bases, m being zero or any integer greater than or equal to 1, provided that at least one base remains unused in the X n and Y m sequences, and that the sequence of X n bases is not complementary to the sequence of Y m bases; (iii) wherein the base adjacent the 5' end of X n and the base adjacent the 5' end of Y m are selected from the set Q, which consists of not N and not M; and (iv) wherein the nontarget sequence differs by the identity of at least one base, Z, in the X n region or the Y m region; b. combining said four probes under hybridizing conditions with single stranded target or double stranded target or double stranded target separated from its complementary strand; c. while hybridized to target, extending the first probe to fill the X n gap, and optionally the fourth probe to fill the Y m gap, using an excess of deoxy X' triphosphates and deoxy Y' triphosphates, wherein X' and Y' represent the complements of X and Y, respectively, on the target strand but omitting deoxy Z' triphosphates complementary to the single different base in the nontarget gap; d. while hybridized to target, ligating the extended first probe to the second probe, and optionally ligating the extended fourth probe to the third probe, to form at least one double stranded complex of ligated probe hybridized to the target sequence; and e. separating and detecting the properly extended and ligated probes from the improperly extended, unligated probes.
Claim 22
Independent Claim
461 words
A method for distinguishing a first, target nucleic acid sequence from a second, nontarget sequence which differs from the target by the identity of at least one base, said method comprising: a. providing an excess of each of four probes, a first probe complementary to a first segment of the target, a second probe complementary to a second segment of the target, a third probe complementary to the first probe and a fourth probe complementary to the second probe, (i) wherein the 5' end of the first segment of the target is spaced from the 3' end of the second segment by X n bases, each X being independently selected from a set N consisting of from one to any three of the four bases, and n being any integer greater than or equal to 1; (ii) wherein the third probe hybridizes to the first probe, such that the base on the first probe complementary to the 5' end of the third probe is spaced from the 3' end of the first probe by Y m bases, each Y being independently selected from a set M consisting of from zero to any three of the four bases, m being zero or any integer greater than or equal to 1, provided that at least one base remains unused in the X n and Y m sequences, and that the sequence of X n bases is not complementary to the sequence of Y m bases; (iii) wherein the base adjacent the 5' end of X n and the base adjacent the 5' end of Y m are selected from the set Q, which consists of not N and not M; and (iv) wherein the nontarget sequence differs by the identity of at least one base, Z, in the Q region, such that Z is a base contained in the set N, the set M or both; b. combining said four probes under hybridizing conditions with single stranded target or double stranded target or double stranded target separated from its complementary strand; c. while hybridized to target, extending the first probe to fill the X n gap, and optionally the fourth probe to fill the Y m gap, using an excess of deoxy X' triphosphates and deoxy Y' triphosphates, wherein X' and Y' represent the complements of X and Y, respectively, whereby Z fails to terminate extension of the first and optional fourth probes; d. while hybridized to target, ligating the properly extended first probe to the second probe, and optionally ligating the properly extended fourth probe to the third probe, to form at least one double stranded complex of ligated probe hybridized to the target sequence; and e. separating and detecting the properly extended and ligated probes from the improperly extended, unligated probes.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.